Form 4 for MA Mastercard
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001141391-24-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | M - OptEx | $203.42 | +16.0K | 19.4K | +482% | +$3.26M |
| DM | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | F - Tax | $475.70 | -1,371 | 11.2K | -11% | -$652.2K |
| DM | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | A - Grant | $0.00 | +8,321 | 19.2K | +76% | $0 |
| DM | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | S - Sale+OE | $475.94 | -16.0K | 12.3K | -57% | -$7.63M |
| DM | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | M - OptEx | $0.00 | -16.0K | 6,157 | -72% | $0 |
| D | 2024-03-05 | 2024-03-01 | MA | Madabhushi Venkata R | CMO | A - Grant | $0.00 | +5,770 | 5,770 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-01 | M | A | 8,927 | $227.25 | 28,291.79 | D | — | — | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. |
| 2 | Common | Class A Common Stock | 2024-03-01 | F | D | 339 | $475.70 | 12,897.79 | D | — | — | (F7) Represents withholding of shares to pay tax liability incident to the settlement of performance stock units that were fully earned and vested on March 1, 2023, and settled on March 1, 2024. |
| 3 | Common | Class A Common Stock | 2024-03-01 | A | A | 2,014 | $0.00 | 13,236.79 | D | — | — | (F6) Award of restricted stock units that will vest in three (3) equal annual installments beginning March 1, 2025. |
| 4 | Common | Class A Common Stock | 2024-03-01 | F | D | 1,032 | $475.70 | 11,222.79 | D | — | — | (F5) Represents withholding of shares to pay tax liability incident to the vesting of restricted stock units. |
| 5 | Common | Class A Common Stock | 2024-03-01 | M | A | 7,110 | $173.49 | 19,364.79 | D | — | — | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. |
| 6 | Common | Class A Common Stock | 2024-03-01 | A | A | 6,307 | $0.00 | 19,204.79 | D | — | — | (F8) Represents earned performance stock units granted on March 1, 2021 that contained performance-vesting requirements. The award was fully earned and vested on March 1, 2024, but will settle on March 1, 2025. |
| 7 | Common | Class A Common Stock | 2024-03-01 | S | D | 3,168 | $474.64 | 25,123.79 | D | — | — | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. (F2) The price reported reflects the weighted average price of shares sold in multiple transactions at prices ranging from $474.21 to $475.18. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within this range. |
| 8 | Common | Class A Common Stock | 2024-03-01 | S | D | 6,913 | $475.88 | 18,210.79 | D | — | — | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. (F3) The price reported reflects the weighted average price of shares sold in multiple transactions at prices ranging from $475.25 to $476.24. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within this range. |
| 9 | Common | Class A Common Stock | 2024-03-01 | S | D | 5,956 | $476.70 | 12,254.79 | D | — | — | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. (F4) The price reported reflects the weighted average price of shares sold in multiple transactions at prices ranging from $476.26 to $477.1. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within this range. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2024-03-01 | M | D | 7,110 | $0.00 | 0 | D | $173.49 · — to 2028-03-01 | 7,110 Class A Common Stock | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. (F9) The reporting person was awarded 16,504 employee stock options on March 1, 2018, which had fully vested. |
| 11 | Derivative | Employee Stock Option (right ro buy) | 2024-03-01 | A | A | 5,770 | $0.00 | 5,770 | D | $476.63 · — to 2034-03-01 | 5,770 Class A Common Stock | (F11) The employee stock options vest in three (3) equal annual installments beginning March 1, 2025. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2024-03-01 | M | D | 8,927 | $0.00 | 6,157 | D | $227.25 · — to 2029-03-01 | 8,927 Class A Common Stock | (F1) The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on November 28, 2023. (F10) The reporting person was awarded 15,084 employee stock options on March 1, 2019, which had fully vested. |